Objective: to explore the effect of minimally invasive neurosurgery and craniotomy on hypertensive cerebral hemorrhage. Methods: 60 patients with hypertensive cerebral hemorrhage admitted from January 2018 to December...Objective: to explore the effect of minimally invasive neurosurgery and craniotomy on hypertensive cerebral hemorrhage. Methods: 60 patients with hypertensive cerebral hemorrhage admitted from January 2018 to December 2020 were randomly divided into the control group and the experimental group, which were treated with conventional craniotomy and minimally invasive neurosurgical hematoma removal respectively. Results: the SF-36 score of the experimental group was significantly improved, the NIHSS score was significantly reduced, and each time index was significantly shorter, the intraoperative blood loss and hospitalization expenses were significantly less, the wound length was significantly shorter, the hematoma clearance rate, GOS score and treatment satisfaction were significantly higher, the complication rate and disability rate were significantly lower, the difference between the two groups was significant (p < 0.05);However, there was no significant difference in the total effective rate of clinical treatment (P>0.05). Conclusion: compared with craniotomy, neurosurgery minimally invasive hematoma removal has a better effect in the treatment of hypertensive cerebral hemorrhage. It can not only improve SF-36 score, treatment satisfaction, hematoma removal rate and GOS score, but also shorten the hematoma disappearance time, operation time, hospitalization time and ICU stay time. At the same time, it can reduce intraoperative blood loss and hospitalization expenses and shorten the wound length.展开更多
文摘Objective: to explore the effect of minimally invasive neurosurgery and craniotomy on hypertensive cerebral hemorrhage. Methods: 60 patients with hypertensive cerebral hemorrhage admitted from January 2018 to December 2020 were randomly divided into the control group and the experimental group, which were treated with conventional craniotomy and minimally invasive neurosurgical hematoma removal respectively. Results: the SF-36 score of the experimental group was significantly improved, the NIHSS score was significantly reduced, and each time index was significantly shorter, the intraoperative blood loss and hospitalization expenses were significantly less, the wound length was significantly shorter, the hematoma clearance rate, GOS score and treatment satisfaction were significantly higher, the complication rate and disability rate were significantly lower, the difference between the two groups was significant (p < 0.05);However, there was no significant difference in the total effective rate of clinical treatment (P>0.05). Conclusion: compared with craniotomy, neurosurgery minimally invasive hematoma removal has a better effect in the treatment of hypertensive cerebral hemorrhage. It can not only improve SF-36 score, treatment satisfaction, hematoma removal rate and GOS score, but also shorten the hematoma disappearance time, operation time, hospitalization time and ICU stay time. At the same time, it can reduce intraoperative blood loss and hospitalization expenses and shorten the wound length.
